Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.34), $0.01 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.